Follistatin (FS) is a single chain glycoprotein that has been shown to irreversibly bind and neutralize activin, a pleotropic growth factor in the TGF-beta superfamily. Although transcribed from a single gene, alternative splicing and post-translational proteolytic modifications produce 3 FS core proteins differing in their c-terminus, tissue distribution, and in their biochemical and physiological properties. Since activin is a critical regulator of ovarian folliculogenesis, bone formation, tissue fate determination, and other developmental and physiological processes, and FS expression largely overlaps that of activin, FS actually functions as a critical """"""""on/off switch"""""""" in governing the biological actions of activin. In addition, activin is a critical regulator of granulosa cell proliferation and differentiation within developing follicles. Since FS production increases throughout follicular development and granulosa ells secrete both activin and FS, it is clear that the interplay between these two molecules influences how granulosa cells and follicles mature during the normal menstrual cycle. Moreover, our preliminary studies indicate that the different FS forms may have different activin-regulating functions. Thus, the broad goal of this proposal is to define the regulatory mechanisms and cellular consequences of post-transcriptional proteolytic processing of FS315, a process which ultimately determines the function and distribution of FS within the body and developing follicle. In the first Specific Aim, we propose to isolate and purify the FS315 processing protease using a cell line that we have demonstrated has this important proteolytic activity. Once cloned, hormonal regulation of expression and activity will be determined. The second Specific Aim focuses on the intracellular location of this protease and the distribution of processed and unprocessed FS inside and outside the cell. In the third Specific Aim we will characterize the functional differences between unprocessed and processed FS, examining both extracellular and potential intracellular activities of FS and activin. The studies will result in a better understanding of how different forms of FS are produced in different tissues as well as their biological activities, a necessary prerequisite to elucidate the physiology of FS in the human.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK055838-04
Application #
6626979
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Blondel, Olivier
Project Start
2000-01-15
Project End
2004-12-31
Budget Start
2003-01-01
Budget End
2003-12-31
Support Year
4
Fiscal Year
2003
Total Cost
$285,452
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Sidis, Yisrael; Mukherjee, Abir; Keutmann, Henry et al. (2006) Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 147:3586-97
Xia, Yin; Sidis, Yisrael; Mukherjee, Abir et al. (2005) Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis. Endocrinology 146:3614-21
Saito, Seiichiro; Sidis, Yisrael; Mukherjee, Abir et al. (2005) Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3. Endocrinology 146:5052-62
Schneyer, Alan L; Wang, Qifa; Sidis, Yisrael et al. (2004) Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. J Clin Endocrinol Metab 89:5067-75
Schneyer, Alan (2004) Inhibins: a historical perspective. Semin Reprod Med 22:161-4
Schneyer, Alan; Schoen, Amy; Quigg, Alicia et al. (2003) Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology 144:1671-4
Welt, Corrine; Sidis, Yisrael; Keutmann, Henry et al. (2002) Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 227:724-52
Sidis, Yisrael; Tortoriello, Drew V; Holmes, William E et al. (2002) Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology 143:1613-24
Tortoriello, D V; Sidis, Y; Holtzman, D A et al. (2001) Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 142:3426-34
Fujiwara, T; Sidis, Y; Welt, C et al. (2001) Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles. J Clin Endocrinol Metab 86:4206-15

Showing the most recent 10 out of 12 publications